Showing results (261-270 of 290) with videos related to

Sort By:
Pageof 29
Cancer Immunology Research|September 28, 2016
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeDouglas B Johnson, Garrett M Frampton, Matthew J Rioth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2015
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400Roy S Herbst, David R Gandara, Fred R Hirsch, et al.
Journal of the National Cancer Institute|January 26, 2018
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal CancerFilippo Pietrantonio, Federica Di Nicolantonio, Alexa B Schrock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2014
Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancerRinath Jeselsohn, Roman Yelensky, Gilles Buchwalter, et al.
International Journal of Cancer|July 13, 2024
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profilingJacqueline A Turner, Robert J Van Gulick, William A Robinson, et al.
Cancer Discovery|December 21, 2013
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targetsJustin M Balko, Jennifer M Giltnane, Kai Wang, et al.
The Journal of Clinical Investigation|September 5, 2019
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinomaAllen S Ho, Angelica Ochoa, Gowtham Jayakumaran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung CancerVassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
The Oncologist|August 28, 2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersKim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.
Oncotarget|July 15, 2015
Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screeningJeeyun Lee, Hee Cheol Kim, Jung Yong Hong, et al.
Pageof 29